Aller au contenu principal
Profil bibliographique

Marios Tzavelas

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

4Publications signalées
20Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Acute Ischemic Stroke ManagementDiabetes, Cardiovascular Risks, and LipoproteinsLiver Disease and TransplantationLiver Disease Diagnosis and TreatmentLipoproteins and Cardiovascular Health

Les publications récentes

Accès ouvert 2022 article OpenAlex

The Predictive Role of the Triglyceride/Glucose Index in Patients with Hypercholesterolemia and Acute Ischemic Stroke

Christodoula Kourtidou, Eleftheria Ztriva, Danai-Thomais Kostourou, Georgios Polychronopoulos et autres

Background: The triglyceride/glucose index (TyG) reflects insulin resistance and predicts the risk of acute ischemic stroke (aIS). However, it is uncertain if this index predicts the severity and outcome of aIS because studies that addressed this question are few and all were …

gr (code pays fourni par la source)

2 citations Reviews in Cardiovascular Medicine
2022 article OpenAlex

SERUM URIC ACID LEVELS APPEAR TO PREDICT IN-HOSPITAL MORTALITY IN PATIENTS ADMITTED WITH ACUTE ISCHEMIC STROKE

Alexandra Tsankof, Evripidis Valanikas, Erofili Papathanasiou, Georgios Polychronopoulos et autres

Objective: Previous studies reported discrepant results regarding the association between serum uric acid levels and the outcome of acute ischemic stroke. We aimed to evaluate this association. Design and method: We prospectively studied 1,107 consecutive patients who were admitted for acute ischemic …

gr (code pays fourni par la source)

1 citation Journal of Hypertension
2021 article OpenAlex

Heterozygous familial hypercholesterolemia: prevalence and control rates

Georgios Polychronopoulos, Marios Tzavelas, Konstantinos Tziomalos

Introduction: Heterozygous familial hypercholesterolemia (heFH) is associated with a very high risk for cardiovascular events. Treatment with potent statins substantially reduces cardiovascular morbidity in these patients. Moreover, combination therapy with statins plus ezetimibe and/or proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors facilitates …

gr (code pays fourni par la source)

17 citations Expert Review of Endocrinology & Metabolism

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.